Nevertheless, there is a huge controversy about the role of iNOS in colon cancer [16–20], and this approach offers a limited therapeutic benefit in contexts where constitutive isoforms are the main or even the only source of NO [44]. Here, NOS2 is linked to malignant colon neoplasm.